World-first liquid biopsy for blood cancers promises less invasive, more precise and effective treatments
12,000+ Australians diagnosed with blood cancers each year could soon have access to a simple blood test to monitor their disease thanks to a world-first ‘liquid biopsy’ developed at Peter MacCallum Cancer Centre.
The liquid biopsy for blood cancers developed by Associate Professor Sarah-Jane Dawson and Professor Mark Dawson, promises a new era of less invasive, more precise and effective management of blood cancers, in place of painful bone marrow or lymph node biopsies.
